Journal of the Chemical Society. Perkin transactions I p. 3017 - 3026 (1991)
Update date:2022-08-05
Topics:
Carroll, F. Ivy
Abraham, Philip
Gaetano, Kevan
Mascarella, S. Wayne
Wohl, Ronald A.
et al.
(3S)-3-Hydroxyquinidine, the major metabolite of the Cinchona alkaloid quinidine, was prepared by synthetic chemical modification or microbial oxidation of quinidine.The structure of this metabolite has been demonstrated to be (3S)-3-hydroxyquinidine by 1H and 13C NMR, IR, UV and mass spectral analysis.Previously published comparisons of the 13C NMR spectra of 3-hydroxyquinidine and model compounds were used to establish the absolute stereochemistry of the metabolite (see ref. 8).This assignment has been verified by single-crystal X-ray analysis of (3S)-3-hydroxyquinidine methanesulphonate.The gas- and solution-phase conformational preference of the metabolite derived from molecular modelling and NOE studies are compared with the conformation observed by X-ray crystallography.
View MoreContact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
jiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
Doi:10.1016/j.poly.2012.05.031
(2012)Doi:10.1055/s-0035-1560198
(2016)Doi:10.1007/s10593-012-1039-6
(2012)Doi:10.1002/anie.201201288
(2012)Doi:10.1016/j.tet.2014.06.061
(2014)Doi:10.1039/c5ra21963a
(2015)
